Publication Category: Medications
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
- Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, Mao H, Zhang S, Ahmad NN, Bunck MC, Benabbad I, Zhang XM; SURMOUNT-2 investigators. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Lancet
GLP-1 receptor agonism and GIP receptor antagonism induce substantial alterations in enteroendocrine and islet cell populations in obese high fat fed mice
-
Sridhar A, Khan D, Flatt PR, Moffett CR, Irwin N.
GLP-1 receptor agonism and GIP receptor antagonism induce substantial alterations in enteroendocrine and islet cell populations in obese high fat fed mice Peptides
Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial
- Coelho C, Dobbie LJ, Crane J, Douiri A, Learoyd AE, Okolo O, Panagiotopoulos S, Pournaras DJ, Ramar S, Rubino F, Singhal R, le Roux CW, Taheri S, McGowan B. Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial Int J Obes (Lond)
Pharmacotherapy before and after bariatric surgery
-
Alabduljabbar K, le Roux CW.
Pharmacotherapy before and after bariatric surgery Metabolism
Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
-
Alabduljabbar K, Alsaqaaby M, Neff KJ, Crotty M, le Roux CW.
Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting Endocrine
Glucagon-like peptide-1 therapy in people with obesity restores natural killer cell metabolism and effector function
-
De Barra C, Khalil M, Mat A, O'Donnell C, Shaamile F, Brennan K, O'Shea D, Hogan AE.
Glucagon-like peptide-1 therapy in people with obesity restores natural killer cell metabolism and effector function Obesity (Silver Spring)
Pharmacotherapy for chronic obesity management: a look into the future
-
Abdel-Malek M, Yang L, Miras AD.
Pharmacotherapy for chronic obesity management: a look into the future Intern Emerg Med
The Metreleptin Effectiveness and Safety Registry (MEASuRE): concept, design and challenges
-
Haymond MW, Araújo-Vilar D, Balser J, Lewis JH, Louzado R, Musso C, von Schnurbein J, Wabitsch M; MEASuRE group.
The Metreleptin Effectiveness and Safety Registry (MEASuRE): concept, design and challenges Orphanet J Rare Dis